论文部分内容阅读
流行性出血性急性结膜炎缺乏特效药物治疗。我院过去曾用4%吗啉双胍眼药水疱疹净眼药水、三氮唑核苷眼药水(病毒唑眼药水)均不够理想。孟丽等曾报导0.05%阿托品点眼液有抵抗HSV—1型疱疹病毒的作用,我们使用这种方法治疗本病,取得较明显效果。现报导如下。病例简况及治疗:1988年7～8月2个月流行性出血性急性结膜炎共计50例。均有传染接触史,有结膜下出血点,部分病例伴眼脸浮肿,个别有耳前淋巴结压痛及头痛。其中25侧使用三氮唑核苷眼药水,另
Epidemic hemorrhagic acute conjunctivitis lacks specific drug treatment. In the past, our hospital used morpholine biguanide eye drops herpes eye drops, ribavirin eye drops (ribavirin eye drops) are not ideal. Meng Li et al reported that 0.05% atropine eye drops have a resistance to HSV-1 herpes virus role, we use this method of treatment of the disease, and achieved more significant results. Now reported as follows. Case description and treatment: 1988 July to August 2 months, a total of 50 cases of acute hemorrhagic conjunctivitis. Have contact history of infection, there are subconjunctival hemorrhage, some cases with eyelid edema, individual pre-ear lymph nodes tenderness and headache. Of which 25 sides using ribavirin eyedrops, the other